241
Views
137
CrossRef citations to date
0
Altmetric
Research Article

5-HT Receptors: Subtypes and Second Messengers

&
Pages 197-214 | Published online: 26 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Boris Nemets, Bella Talesnick, Robert H Belmaker & Joseph Levine. (2002) Myo-inositol has no Beneficial Effect on Premenstrual Dysphoric Disorder. The World Journal of Biological Psychiatry 3:3, pages 147-149.
Read now
Cathy Vaillancourt, Alain Petit, Nicole Gallo-Payet, Diego Bellabarba, Jean-Guy Lehoux & Serge Bélisle. (1994) Labelling of D2-Dopaminergic and 5-HT2-Serotonergic Binding Sites in Human Trophoblatic Cells Using [3H]-Spiperone. Journal of Receptor Research 14:1, pages 11-22.
Read now
W E Childers$suffix/text()$suffix/text(). (1992) Patent Update: Serotonergic Agents: June-December 1991. Current Opinion on Therapeutic Patents 2:2, pages 163-175.
Read now

Articles from other publishers (134)

Nicholas M. Barnes, Gerard P. Ahern, Carine Becamel, Joël Bockaert, Michael Camilleri, Severine Chaumont-Dubel, Sylvie Claeysen, Kathryn A. Cunningham, Kevin C. Fone, Michael Gershon, Giuseppe Di Giovanni, Nathalie M. Goodfellow, Adam L. Halberstadt, Rachel M. Hartley, Ghérici Hassaine, Katharine Herrick-Davis, Ruud Hovius, Enza Lacivita, Evelyn K. Lambe, Marcello Leopoldo, Finn Olav Levy, Sarah C. R. Lummis, Philippe Marin, Luc Maroteaux, Andrew C. McCreary, David L. Nelson, John F. Neumaier, Adrian Newman-Tancredi, Hugues Nury, Alexander Roberts, Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts & Daniel Hoyer. (2020) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacological Reviews 73:1, pages 310-520.
Crossref
Anna Beyeler, Anes Ju, Abdeslam Chagraoui, Lise Cuvelle, Maxime Teixeira, Giuseppe Di Giovanni & Philippe De Deurwaerdère. 2021. 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B. 5-HT Interaction with Other Neurotransmitters: Experimental Evidence and Therapeutic Relevance - Part B 3 39 .
Daniel Hoyer. 2019. The Serotonin System. The Serotonin System 63 93 .
Giuseppe Di Giovanni & Philippe De Deurwaerdère. (2018) TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?. Neuropharmacology 142, pages 20-29.
Crossref
Brian Furman. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Philippe De Deurwaerdère, Guillaume Drutel & Giuseppe Di Giovanni. 2018. 5-HT2A Receptors in the Central Nervous System. 5-HT2A Receptors in the Central Nervous System 3 29 .
Daniel Hoyer. (2017) 5-HT Receptor Nomenclature: Naming Names, Does It Matter? A Tribute to Maurice Rapport. ACS Chemical Neuroscience 8:5, pages 908-919.
Crossref
Julia Kleeblatt, Felix Betzler, Laura L. Kilarski, Tom Bschor & Stephan Köhler. (2017) Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence. European Neuropsychopharmacology 27:5, pages 423-441.
Crossref
Jigna Rajesh Kumar, Ramamoorthy Rajkumar, Liying Corinne Lee & Gavin S. Dawe. (2016) Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors. Neuropharmacology 110, pages 1-14.
Crossref
E. D. Larson, A. Vandenbeuch, A. Voigt, W. Meyerhof, S. C. Kinnamon & T. E. Finger. (2015) The Role of 5-HT3 Receptors in Signaling from Taste Buds to Nerves. Journal of Neuroscience 35:48, pages 15984-15995.
Crossref
Mun Hee Kim & Yea Hyun Leem. (2014) Chronic exercise improves repeated restraint stress-induced anxiety and depression through 5HT1A receptor and cAMP signaling in hippocampus. Journal of Exercise Nutrition and Biochemistry 18:1, pages 97-104.
Crossref
Maria T Barrús, Jesus Marín, Jose Villamor & Gloria Balfagón. (1992) Receptors Involved in the Modulation of 5-Hydroxytryptamine Release in Bovine Cerebral Arteries. Journal of Pharmacy and Pharmacology 44:10, pages 824-829.
Crossref
J Hardcastle, P T Hardcastle, P H M Klaren, C J Taylor & S J White. (1999) The Action of 5-Hydroxytryptamine on Normal and Cystic Fibrosis Mouse Colon: Effects on Secretion and Intracellular Calcium. Journal of Pharmacy and Pharmacology 51:4, pages 449-456.
Crossref
Jinbin Xu, Wenhua Chu, Zhude Tu, Lynne A. Jones, Robert R. Luedtke, Joel S. Perlmutter, Mark A. Mintun & Robert H. Mach. (2009) [ 3 H]4‐(Dimethylamino)‐ N ‐[4‐(4‐(2‐methoxyphenyl)piperazin‐ 1‐yl)butyl]benzamide, a selective radioligand for dopamine D 3 receptors. I. In vitro characterization . Synapse 63:9, pages 717-728.
Crossref
John A. Gray & Bryan L. Roth. 2007. Handbook of Contemporary Neuropharmacology. Handbook of Contemporary Neuropharmacology.
José Rioja, Luis J. Santín, Alicia Doña, Laura de Pablos, Francisco J. Minano, Salvador Gonzalez-Baron & Jose A. Aguirre. (2006) 5-HT1A receptor activation counteracts c-Fos immunoreactivity induced in serotonin neurons of the raphe nuclei after immobilization stress in the male rat. Neuroscience Letters 397:3, pages 190-195.
Crossref
Hatan Kang, Won Kyu Lee, Yun Hui Choi, Krishna Moorthy Vukoti, Won Gi Bang & Yeon Gyu Yu. (2005) Molecular analysis of the interaction between the intracellular loops of the human serotonin receptor type 6 (5-HT6) and the α subunit of GS protein. Biochemical and Biophysical Research Communications 329:2, pages 684-692.
Crossref
Seema Saksena, Ravinder K. Gill, Sangeeta Tyagi, Waddah A. Alrefai, Zaheer Sarwar, Krishnamurthy Ramaswamy & Pradeep K. Dudeja. (2005) Involvement of c-Src and Protein Kinase Cδ in the Inhibition of Cl-/OH- Exchange Activity in Caco-2 Cells by Serotonin. Journal of Biological Chemistry 280:12, pages 11859-11868.
Crossref
Timo Heinrich, Henning Böttcher, Gerd D. Bartoszyk, Hartmut E. Greiner, Christoph A. Seyfried & Christoph van Amsterdam. (2004) Indolebutylamines as Selective 5-HT 1A Agonists . Journal of Medicinal Chemistry 47:19, pages 4677-4683.
Crossref
Michael T. Isaac, Maria B. Isaac, Fidel Gallo & Alan Tournoux. (2003) Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency. Human Psychopharmacology: Clinical and Experimental 18:8, pages 595-601.
Crossref
Bengt Andrée, Ann Hedman, Seth-Olav Thorberg, Dag Nilsson, Christer Halldin & Lars Farde. (2003) Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain. Psychopharmacology 167:1, pages 37-45.
Crossref
Miklos Toth. (2003) 5-HT1A receptor knockout mouse as a genetic model of anxiety. European Journal of Pharmacology 463:1-3, pages 177-184.
Crossref
F Miranda, E Hong, H Sánchez & D.N Velázquez-Martı́nez. (2003) Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT1A/1B/2C receptors. Pharmacology Biochemistry and Behavior 74:2, pages 371-380.
Crossref
P Janssen, N H Prins, A L Meulemans & R A Lefebvre. (2002) Smooth muscle 5-HT 2A receptors mediating contraction of porcine isolated proximal stomach strips . British Journal of Pharmacology 137:8, pages 1217-1224.
Crossref
Zdzisław Chilmonczyk, Krzysztof J Krajewski & Jacek Cybulski. (2002) Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists. Il Farmaco 57:11, pages 917-923.
Crossref
Hildegard Schuller. 2002. Site-Selective Neurotoxicity. Site-Selective Neurotoxicity 94 115 .
L. Pinilla, L. C. González, M. Tena-Sempere & E. Aguilar. (2001) Interactions between serotoninergic and aminoacidergic pathways in the control of PRL secretion in prepubertal male ratsInteracción entre las vías serotoninérgica y aminoacidérgica en el control de la secreción de PRL en ratas macho prepúber. Journal of Physiology and Biochemistry 57:3, pages 237-244.
Crossref
Francesc Artigas, Pau Celada, Marc Laruelle & Albert Adell. (2001) How does pindolol improve antidepressant action?. Trends in Pharmacological Sciences 22:5, pages 224-228.
Crossref
Agnieszka Bronowska, Andrzej Leś, Zdzislaw Chilmonczyk, Slawomir Filipek, Øyvind Edvardsen, Roy Østensen & Ingebrigt Sylte. (2001) Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors. Bioorganic & Medicinal Chemistry 9:4, pages 881-895.
Crossref
Frederick E. Miller. (2001) Strategies for the rapid treatment of depression. Human Psychopharmacology: Clinical and Experimental 16:2, pages 125-132.
Crossref
William P. Clarke, Kelly A. Berg, Georgianna Gould & Alan Frazer. (2001) Characterization of 5‐HT 1A,B and 5‐ HT 2A,C Serotonin Receptor Binding . Current Protocols in Pharmacology 12:1.
Crossref
RS Martin & GR Martin. (2016) Investigations into Migraine Pathogenesis: Time Course for Effects of m-CPP, BW723C86 or Glyceryl Trinitrate on Appearance of Fos-Like Immunoreactivity in Rat Trigeminal Nucleus Caudalis (TNC). Cephalalgia 21:1, pages 46-52.
Crossref
Wolfgang Auch–Schwelk, Ingo Paetsch, Florian Krackhardt, Michael Gräfe, Roland Hetzer & Eckart Fleck. (2000) Modulation of Contractions to Ergonovine and Methylergonovine by Nitric Oxide and Thromboxane A2 in the Human Coronary Artery. Journal of Cardiovascular Pharmacology 36:5, pages 631-639.
Crossref
Diana Martinez, Allegra Broft & Marc Laruelle. (2000) Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies. Biological Psychiatry 48:8, pages 844-853.
Crossref
M E Castro, P J Harrison, A Pazos & T Sharp. (2002) Affinity of (±)‐Pindolol, (‐)‐Penbutolol, and (‐)‐Tertatolol for Pre‐ and Postsynaptic Serotonin 5‐HT 1A Receptors in Human and Rat Brain . Journal of Neurochemistry 75:2, pages 755-762.
Crossref
Diana Martinez, Osama Mawlawi, Dah-Ren Hwang, Justine Kent, Norman Simpson, Ramin V Parsey, Tomoki Hashimoto, Mark Slifstein, Yiyun Huang, Ronald Van Heertum, Anissa Abi-Dargham, Stephen Caltabiano, Andrea Malizia, Hugh Cowley, J.John Mann & Marc Laruelle. (2000) Positron emission tomography study of pindolol occupancy of 5-HT1A receptors in humans: preliminary analyses. Nuclear Medicine and Biology 27:5, pages 523-527.
Crossref
Ildefonso Hervás, Claudio M T Queiroz, Albert Adell & Francesc Artigas. (2009) Role of uptake inhibition and autoreceptor activation in the control of 5‐HT release in the frontal cortex and dorsal hippocampus of the rat. British Journal of Pharmacology 130:1, pages 160-166.
Crossref
Alain Borgeat. 2000. On the Study and Practice of Intravenous Anaesthesia. On the Study and Practice of Intravenous Anaesthesia 275 285 .
M. Göthert & E. Schlicker. 2000. Serotoninergic Neurons and 5-HT Receptors in the CNS. Serotoninergic Neurons and 5-HT Receptors in the CNS 307 350 .
Smriti M Agrawal & Robert J Omeljaniuk. (1999) Specific binding of [ 3 H]ketanserin to hypothalamus membranes of juvenile rainbow trout, Oncorhynchus mykiss ? . Canadian Journal of Physiology and Pharmacology 78:1, pages 58-66.
Crossref
I.D Hentall, P.J Kurle & T.R White. (1999) Correlations between serotonin level and single-cell firing in the rat's nucleus raphe magnus. Neuroscience 95:4, pages 1081-1088.
Crossref
Hisashi Yamamoto, Katsuhiko Shimizu, Akiko Tachibana & Nobuhiro Fusetani. (1999) Roles of dopamine and serotonin in larval attachment of the barnacle,Balanus amphitrite. Journal of Experimental Zoology 284:7, pages 746-758.
Crossref
D.C. ChuganiK. NiimuraS. ChaturvediO. MuzikM. FakhouriM.-L. LeeH.T. Chugani. (1999) Increased brain serotonin synthesis in migraine. Neurology 53:7, pages 1473-1473.
Crossref
Andreu Raurich, Guadalupe Mengod, Francesc Artigas & Roser Cort�s. (1999) Displacement of the binding of 5-HT1A receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Synapse 34:1, pages 68-76.
Crossref
Robert M Berman, Amit Anand, Angela Cappiello, Helen L Miller, X.Sylvia Hu, Dan A Oren & Dennis S Charney. (1999) The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biological Psychiatry 45:9, pages 1170-1177.
Crossref
Nasser Haddjeri, Claude de Montigny & Pierre Blier. (1999) Modulation of the firing activity of rat serotonin and noradrenaline neurons by (±)pindolol. Biological Psychiatry 45:9, pages 1163-1169.
Crossref
Ago Rinken, Sergi Ferré, Anton Terasmaa, Christer Owman & Kjell Fuxe. (1999) Serotonergic agonists behave as partial agonists at the dopamine D2 receptor. NeuroReport 10:3, pages 493-495.
Crossref
Franz X. Vollenweider, Margreet F. I. Vollenweider-Scherpenhuyzen, Andreas Bäbler, Helen Vogel & Daniel Hell. (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 9:17, pages 3897-3902.
Crossref
Jun Yamada, Yumi Sugimoto & Tomoko Yoshikawa. (1998) p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors. European Journal of Pharmacology 359:2-3, pages 185-190.
Crossref
Jun Yamada, Yumi Sugimoto, Toshiko Noma & Tomoko Yoshikawa. (1998) Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats. European Journal of Pharmacology 359:1, pages 81-86.
Crossref
Christopher L. Parks, Patricia S. Robinson, Etienne Sibille, Thomas Shenk & Miklos Toth. (1998) Increased anxiety of mice lacking the serotonin 1A receptor . Proceedings of the National Academy of Sciences 95:18, pages 10734-10739.
Crossref
Kirsten Krebs-Thomson, Virginia Lehmann-Masten, Shahrouz Naiem, Martin P Paulus & Mark A Geyer. (1998) Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin. European Journal of Pharmacology 343:2-3, pages 135-143.
Crossref
A Wolf, M Caldarola-Pastuszka & L Uphouse. (1998) Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT2A/2C receptor agonists. Brain Research 779:1-2, pages 84-95.
Crossref
Misako Doi-Saika, Atsushi Tokunaga & Emiko Senba. (1997) Intradermal 5-HT induces Fos expression in rat dorsal horn neurons not via 5-HT3 but via 5-HT2A receptors. Neuroscience Research 29:2, pages 143-149.
Crossref
B Cao. (1997) Influence of 5-HT1A Receptor Antagonism on Plus-Maze Behaviour in Mice. I. Pindolol Enantiomers and Pindobind 5-HT1A. Pharmacology Biochemistry and Behavior 58:2, pages 583-591.
Crossref
Mary C Wolff & J.David Leander. (1997) Differentiation of 5-HT1A receptor ligands by drug discrimination. European Journal of Pharmacology 333:2-3, pages 113-122.
Crossref
Rona J. DelaySue C. Kinnamon & Stephen D. Roper. (1997) Serotonin Modulates Voltage-Dependent Calcium Current in Necturus Taste Cells . Journal of Neurophysiology 77:5, pages 2515-2524.
Crossref
Valérie Audinot, Sonia Lochon, Adrian Newman-Tancredi, Gilbert Lavielle & Mark J Millan. (1997) Binding profile of the novel 5-HT1B/1D receptor antagonist, [3H]GR125,743, in guinea-pig brain: a comparison with [3H]5-carboxamidotryptamine. European Journal of Pharmacology 327:2-3, pages 247-256.
Crossref
Nicolaas H. Prins, Michel R. Briejer & Jan A.J. Schuurkes. (1997) Characterization of the contraction to 5-HT in the canine colon longitudinal muscle. British Journal of Pharmacology 120:4, pages 714-720.
Crossref
I. van Wijngaarden & W. Soudijn. 1997. Serotonin Receptors And Their Ligands. Serotonin Receptors And Their Ligands 161 197 .
I. van Wijngaarden & W. Soudijn. 1997. Serotonin Receptors And Their Ligands. Serotonin Receptors And Their Ligands 87 95 .
I. van Wijngaarden, W. Soudijn & M.Th.M. Tulp. 1997. Serotonin Receptors And Their Ligands. Serotonin Receptors And Their Ligands 17 43 .
LYNDA UPHOUSE. (1997) Multiple Serotonin Receptors: Too Many, Not Enough, or Just the Right Number?. Neuroscience & Biobehavioral Reviews 21:5, pages 679-698.
Crossref
Zdzislaw Chilmonczyk, Agnieszka Szelejewska‐Wozniakowska, Jacek Cybulski, Marcin Cybulski, Anna E. Koziol & Maria Gdaniec. (2006) Conformational Flexibility of Serotonin 1A Receptor Ligands from Crystallographic Data. Updated Model of the Receptor Pharmacophore . Archiv der Pharmazie 330:5, pages 146-160.
Crossref
Luz Romero, Ildefonso Hervás & Francesc Artigas. (1996) The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neuroscience Letters 219:2, pages 123-126.
Crossref
JoséA. Terrón. (1996) GR127935 is a potent antagonist of the 5-HT1-like receptor mediating contraction in the canine coronary artery. European Journal of Pharmacology 300:1-2, pages 109-112.
Crossref
Yoshitaka Nishimura. (1996) Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats. British Journal of Pharmacology 117:6, pages 1325-1333.
Crossref
P. Mazzola-Pomietto, C. S. Aulakh, K. M. Wozniak & D. L. Murphy. (1996) Evidence thatm-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology 123:4, pages 333-339.
Crossref
G. J. Molderings, D. Fr�lich, M. G�thert & J. Likungu. (1996) Inhibition of noradrenaline release via presynaptic 5-HT1Da receptors in human atrium. Naunyn-Schmiedeberg's Archives of Pharmacology 353:3, pages 272-280.
Crossref
Francesc Artigas, Luz Romero, Claude de Montigny & Pierre Blier. (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neurosciences 19:9, pages 378-383.
Crossref
Edward C. Conley. 1996. Ion Channel Factsbook. Ion Channel Factsbook 12 35 .
Sarah Brien. 1996. Addictive Behaviour: Molecules to Mankind. Addictive Behaviour: Molecules to Mankind 191 212 .
Miklos Toth. (1995) Transcriptional regulation of the 5-HT2 receptor. Behavioural Brain Research 73:1-2, pages 183-186.
Crossref
Ling Yang & Cinda J. Helke. (2004) Effects of coexisting neurochemicals on the release of serotonin from the intermediate area of rat thoracic spinal cord. Synapse 21:4, pages 319-323.
Crossref
N.A. Manuel, D.I. Wallis & H. Crick. (1995) Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. British Journal of Pharmacology 116:6, pages 2647-2654.
Crossref
Y. Nishimura & A. Suzuki. (1995) ENHANCED CONTRACTILE RESPONSES MEDIATED BY DIFFERENT 5-HT RECEPTOR SUBTYPES IN BASILAR ARTERIES, SUPERIOR MESENTERIC ARTERIES AND THORACIC AORTAS FROM STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology 22:s1, pages S99-S101.
Crossref
C. Drieu la Rochelle & S.E. O'Connor. (2012) Sumatriptan‐induced saphenous venoconstriction in the anaesthetized dog through 5‐HT 1 ‐like receptor activation . British Journal of Pharmacology 116:4, pages 2207-2212.
Crossref
E. Przegaliński, E. Moryl & M. Papp. (1995) The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression. Neuropharmacology 34:10, pages 1305-1310.
Crossref
Mark Berner Hansen. (1995) SEROTONIN - AN INTESTINAL SECRETAGOGUE - Receptor Subtypes and Intracellular Mediators. Pharmacology & Toxicology 77, pages 1-40.
Crossref
J. T. Little, A. Broocks, A. Martin, J. L. Hill, L. E. Tune, C. Mack, M. Cantillon, S. Molchan, D. L. Murphy & T. Sunderland. (1995) Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans. Psychopharmacology 120:3, pages 280-288.
Crossref
D. Marona-Lewicka & D. E. Nichols. (1995) Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists. Psychopharmacology 120:4, pages 384-391.
Crossref
Michel R. Briejer, Louis M.A. Akkermans, Romain A. Lefebvre & Jan A.J. Schuurkes. (1995) Novel 5-HT2-like receptor mediates neurogenic relaxation of the guinea-pig proximal colon. European Journal of Pharmacology 279:2-3, pages 123-133.
Crossref
P. Brikas. (1995) Investigation into the effects of 5-HT1A and 5-HT2 receptor agonists on the abomasal spiking activity in sheep. Small Ruminant Research 16:3, pages 233-238.
Crossref
Jose Conrado Poblete & Efrain C. Azmitia. (1995) Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor. Brain Research 680:1-2, pages 9-15.
Crossref
Andrew D. Levy, Qian Li, Michael Gustafson & Louis D. Van de Kar. (1995) Neuroendocrine profile of the potential anxiolytic drug S-20499. European Journal of Pharmacology 274:1-3, pages 141-149.
Crossref
A. Choppin & S.E. O'Connor. (2012) Presence of vasoconstrictor 5HT 1 ‐like receptors revealed by precontraction of rabbit isolated mesenteric artery . British Journal of Pharmacology 114:2, pages 309-314.
Crossref
Guy Griebel. (1995) 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research. Pharmacology & Therapeutics 65:3, pages 319-395.
Crossref
Sheila L. Handley. (1995) 5-Hydroxytryptamine pathways in anxiety and its treatment. Pharmacology & Therapeutics 66:1, pages 103-148.
Crossref
H.H.G. Berendsen. (1995) Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?. Pharmacology & Therapeutics 66:1, pages 17-37.
Crossref
David T. George, David J. Nutt, Robert R. Rawlings, Monte J.M. Phillips, Michael J. Eckardt, William Z. Potter & Markku Linnoila. (1995) Behavioral and endocrine responses to clomipramine in panic disorder patients with or without alcoholism. Biological Psychiatry 37:2, pages 112-119.
Crossref
Susan K. Hemrick-Luecke & Ray W. Fuller. (1995) Decreased hypothalamic epinephrine concentration by quipazine and other serotonin agonists in rats. Biochemical Pharmacology 49:3, pages 323-327.
Crossref
P. Mazzola-Pomietto, C. S. Aulakh, K. M. Wozniak, J. L. Hill & D. L. Murphy. (1995) Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors. Psychopharmacology 117:2, pages 193-199.
Crossref
Hervé Canton, Laurence Verrièle & Mark J. Millan. (1994) Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptormediated phosphoinositide (PI) turnover by clozapine in the rat: A comparison to other antipsychotics. Neuroscience Letters 181:1-2, pages 65-68.
Crossref
Ling Yang, Henry M. JacocksIIIIII & Cinda J. Helke. (2004) Release of [ 3 H]5‐hydroxytryptamine from the intermediate area of rat thoracic spinal cord is modulated by presynaptic autoreceptors . Synapse 18:3, pages 198-204.
Crossref
P. BRIKAS, J. FIORAMONTI & L. BUENO. (2008) Types of serotonergic receptors involved in the control of reticulo‐ruminal myoelectric activity in sheep. Journal of Veterinary Pharmacology and Therapeutics 17:5, pages 345-352.
Crossref
M. B. Hansen, J. E. Thorb�ll & E. Skadhauge. (1994) 5-Hydroxytryptamine2 and 5-hydroxytryptamine3 receptors mediate serotonin-induced short-circuit current in pig jejunum. Journal of Comparative Physiology B 164:5, pages 343-348.
Crossref
M.J. Ramírez, J. Del Río, E. Cenarruzabeitia & B. Lasheras. (2012) On the nature of the 5‐HT receptor subtype inhibiting acetylcholine release in the guinea‐pig ileum. British Journal of Pharmacology 113:1, pages 77-80.
Crossref
Larry D. Sanford, Richard J. Ross, Amalia E. Seggos, Adrian R. Morrison, William A. Ball & Graziella L. Mann. (1994) Central administration of two 5-HT receptor agonists: Effect on REM sleep initiation and PGO waves. Pharmacology Biochemistry and Behavior 49:1, pages 93-100.
Crossref
Henriette Frances, Claire Monier & Marcel Debray. (1994) Behavioral effect of beta-blocking drugs resulting from the stimulation or the blockade of serotonergic 5-HT1B receptors. Pharmacology Biochemistry and Behavior 48:4, pages 965-969.
Crossref
H. Crick, N.A. Manuel & D.I. Wallis. (1994) A novel 5-HT receptor or a combination of 5-HT receptor subtypes may mediate depression of a spinal monosynaptic reflex in vitro. Neuropharmacology 33:7, pages 897-904.
Crossref
T. OBIT, A. KABEYAMA & A. NISHIO. (2008) Equine coronary artery responds to 5‐hydroxytryptamine with relaxation in vitro. Journal of Veterinary Pharmacology and Therapeutics 17:3, pages 218-225.
Crossref
Lee-Ming Kow, Charles V. Mobbs & Donald W. Pfaff. (1994) Roles of second-messenger systems and neuronal activity in the regulation of lordosis by neurotransmitters, neuropeptides, and estrogen: A review. Neuroscience & Biobehavioral Reviews 18:2, pages 251-268.
Crossref
Louis D. Van de Kar, Maria C. Alvarez Sanz, Joseph M. Yracheta, Kayoko Kunimoto, Qian Li, Andrew D. Levy & Peter A. Rittenhouse. (1994) ICV injection of the serotonin 5-HT1B agonist CP-93, 129 increases the secretion of ACTH, prolactin, and renin and increases blood pressure by nonserotonergic mechanisms. Pharmacology Biochemistry and Behavior 48:2, pages 429-436.
Crossref
Igor Krisch & Breda Bole-Vunduk. (1994) Behavioral studies on LEK-8804, a new ergoline derivative with potent 5-HT1A receptor agonist and 5-HT2 receptor antagonist activity. Pharmacology Biochemistry and Behavior 47:2, pages 301-305.
Crossref
Pascal Barone, Daniel Jordan, Frédéric Atger, Nicolas Kopp & Gilles Fillion. (1994) Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain. Brain Research 638:1-2, pages 85-94.
Crossref
Daniel J. Cushing, Melvyn Baez, J. David Kursar, Kathryn Schenck & Marlene L. Cohen. (1994) Serotonin-induced contraction in canine coronary artery and saphenous vein: Role of a 5-HT1D-like receptor. Life Sciences 54:22, pages 1671-1680.
Crossref
Marc N. Potenza & Michael R. Lerner. (1994) Characterization of a serotonin receptor endogenous to frog melanophores. Naunyn-Schmiedeberg's Archives of Pharmacology 349:1, pages 11-19.
Crossref
María T. Barrús, Jesús Marín & Gloria Balfagón. (2008) Presynaptic 5‐hydroxytryptamine receptors modulating noradrenaline release in bovine cerebral arteries. Journal of Autonomic Pharmacology 13:6, pages 413-423.
Crossref
Qian Li, Andrew D. Levy, Theresa M. Cabrera, Mark S. Brownfield, George Battaglia & Louis D. Van de Kar. (1993) Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Research 630:1-2, pages 148-156.
Crossref
Daming Ding, Miklos Toth, Yongzhi Zhou, Christopher Parks, Beth J. Hoffman & Thomas Shenk. (1993) Glial cell-specific expression of the serotonin 2 receptor gene: selective reactivation of a repressed promoter. Molecular Brain Research 20:3, pages 181-191.
Crossref
Pascal Barone, Sandrine Millet, Chantal Moret, Nicole Prudhomme & Gilles Fillion. (1993) Quantitative autoradiography of 5-HT1E binding sites in rodent brains: effect of lesion of serotonergic neurones. European Journal of Pharmacology 249:2, pages 221-230.
Crossref
Jacqueline Van Sande, Anouk Allgeier, Claude Massart, Armin Czernilofsky, Gilbert Vassart, Jacques E. Dumont & Carine Maenhaut. (1993) The human and dog 5-HT1D receptors can both activate and inhibit adenylate cyclase in transfected cells. European Journal of Pharmacology: Molecular Pharmacology 247:2, pages 177-184.
Crossref
Edith Hamel, Lyne Grégoire & Benjamin Lau. (1993) 5-HT1 receptors mediating contraction in bovine cerebral arteries: a model for human cerebrovascular ‘5-HT1Dβ‘ receptors. European Journal of Pharmacology 242:1, pages 75-82.
Crossref
S. L. Handley & J. W. McBlane. (1993) 5HT drugs in animal models of anxiety. Psychopharmacology 112:1, pages 13-20.
Crossref
H. LuoA. TesfayeI. SchierenH. S. ChaseJrJr. (1993) Expression of 5-HT1C receptors in transfected MDCK cells is functionally and anatomically asymmetric. American Journal of Physiology-Cell Physiology 265:1, pages C193-C200.
Crossref
Stephan Hjorth & Göran Pettersson. (1993) 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo. European Journal of Pharmacology 238:2-3, pages 357-367.
Crossref
WOLFGANG MEYERHOF, FRANK OBERMÜLLER, SUSANNE FEHR & DIETMAR RICHTER. (1993) A Novel Rat Serotonin Receptor: Primary Structure, Pharmacology, and Expression Pattern in Distinct Brain Regions. DNA and Cell Biology 12:5, pages 401-409.
Crossref
R. SCHLICHTER, D. MOUGINOT, L. CIRANNA & P. FELTZ. (1993) Modulation of GABA A Receptor Channels and Calcium Currents in Cultured Porcine Melanotrophs . Annals of the New York Academy of Sciences 680:1 The Melanotro, pages 199-210.
Crossref
Roger G. Evans, John M. Haynes & John Ludbrook. (1993) Effects of 5-HT-receptor and α2-adrenoceptor ligands on the haemodynamic response to acute central hypovolaemia in conscious rabbits. British Journal of Pharmacology 109:1, pages 37-47.
Crossref
Lennart Svensson, Claudia Fahle, Ernest Hård & Jörgen A. Engel. (1993) Involvement of the serotonergic system in ethanol intake in the rat. Alcohol 10:3, pages 219-224.
Crossref
Anton J.W Scheurink, Henri Leuvenink & Anton B Steffens. (1993) Metabolic and hormonal responses to hypothalamic administration of norfenfluramine in rats. Physiology & Behavior 53:5, pages 889-898.
Crossref
Laszló Hiripi & Roger G.H. Downer. (1993) Characterization of serotonin binding sites in insect (Locusta migratoria) brain. Insect Biochemistry and Molecular Biology 23:2, pages 303-307.
Crossref
R.A. Leslie, J.M. Moorman, A. Coulson & D.G. Grahame-Smith. (1993) Serotonin2/1 C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: evidence for involvement of dorsal raphe nucleus projection fibres. Neuroscience 53:2, pages 457-463.
Crossref
Christiane Malgouris, Fabienne Flamand & Adam Doble. (1993) Autoradiographic studies of RP 62203, a potent 5-HT2 receptor antagonist. Pharmacological characterization of [3H]RP 62203 binding in the rat brain. European Journal of Pharmacology 233:1, pages 37-45.
Crossref
Randolph M. Johnson, Glen T. Inouye, Richard M. Eglen & Erik H. F. Wong. (1993) 5-HT3 receptor ligands lack modulatory influence on acetycholine release in rat entorhinal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology 347:3, pages 241-247.
Crossref
Nancy L. Alsip & Patrick D. Harris. (1992) Serotonin-induced dilation of small arterioles is not mediated via endothelium-derived relaxing factor in skeletal muscle. European Journal of Pharmacology 229:2-3, pages 117-124.
Crossref
Sylvain Loric, Jean-Marie Launay, Jean-François Colas & Luc Maroteaux. (1992) New mouse 5-HT2-like receptor Expression in brain, heart and intestine. FEBS Letters 312:2-3, pages 203-207.
Crossref
Peter A. Rittenhouse, Qian Li, Andrew D. Levy & Louis D. Van de Kar. (1992) Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of renin secretion. Brain Research 593:1, pages 105-113.
Crossref
Denis Richard, Serge Rivest & Catherine Rivier. (1992) The 5-hydroxytryptamine agonist fenfluramine increases fos-like immunoreactivity in the brain. Brain Research 594:1, pages 131-137.
Crossref
Peter A. Rittenhouse, Erica A. Bakkum, Patricia A. O'Connor, Molly Carnes, Cynthia L. Bethea & Louis D. van de Kar. (1992) Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear. Brain Research 580:1-2, pages 205-214.
Crossref
Andrew D. Levy, Peter A. Rittenhouse, Qian Li, Anna M. Bonadonna, Maria C. Alvarez Sanz, Janice E. Kerr, Cynthia L. Bethea & Louis D. van de Kar. (1992) Repeated injections of cocaine inhibit the serotonergic regulation of prolactin and renin secretion in rats. Brain Research 580:1-2, pages 6-11.
Crossref
Begonia Y. Ho, Andreas Karschin, John R. Raymond, Theresa Branchek, Henry A. Lester & Norman Davidson. (1992) Expression in animal cells of the 5-HT 1A receptor by a vaccinia virus vector system . FEBS Letters 301:3, pages 303-306.
Crossref
B Bertin, M Freissmuth, R.M. Breyer, W Schütz, A.D. Strosberg & S Marullo. (1992) Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits.. Journal of Biological Chemistry 267:12, pages 8200-8206.
Crossref
William D. Steers, Michael Albo & Els van Asselt. (2008) Effects of serotonergic agonists on micturition and sexual function in the rat. Drug Development Research 27:4, pages 361-375.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.